Immatics (IMTX) Common Equity (2019 - 2025)
Immatics' (IMTX) quarterly Common Equity came in at $563.5 million in Q4 2025, down 8.26% year-on-year from $614.3 million in Q4 2024, and up 7.16% quarter-over-quarter from $525.9 million in Q2 2025.
Immatics (IMTX) Common Equity (2019 - 2025) Analysis & Trends
Immatics has disclosed Common Equity across 7 years of filings, most recently posting $563.5 million for Q4 2025.
- Common Equity for Q4 2025 came in at $563.5 million, down 8.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $563.5 million (down 8.26% YoY), and the FY2025 annual result was $546.9 million, down 10.96% from the prior year.
- Common Equity came in at $563.5 million for Q4 2025 at Immatics, up from $525.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $614.3 million in Q4 2024 to a low of $27.5 million in Q4 2021.
- The 5-year median for Common Equity is $324.1 million (2023), against an average of $322.2 million.
- Across the five-year window, Common Equity sank 73.58% in 2021 and surged 653.69% in 2022, its largest moves.
- Immatics' Common Equity stood at $27.5 million in 2021, then soared by 653.69% to $207.5 million in 2022, then advanced by 12.86% to $234.1 million in 2023, then jumped by 162.35% to $614.3 million in 2024, then decreased by 8.26% to $563.5 million in 2025.
- The last three Common Equity figures came in at $563.5 million (Q4 2025), $525.9 million (Q2 2025), and $614.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 563.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 563.51 Mn |
| Jun 30, 2025 | 525.88 Mn |
| Dec 31, 2024 | 614.27 Mn |
| Sep 30, 2024 | 416.41 Mn |
| Jun 30, 2024 | 410.58 Mn |
| Mar 31, 2024 | 428.17 Mn |
| Dec 31, 2023 | 234.14 Mn |
| Jun 30, 2023 | 237.62 Mn |
| Dec 31, 2022 | 207.47 Mn |
| Jun 30, 2022 | 133.32 Mn |
| Dec 31, 2021 | 27.53 Mn |
| Jun 30, 2021 | 67.00 Mn |
| Dec 31, 2020 | 104.19 Mn |
| Sep 30, 2020 | 142.11 Mn |
| Dec 31, 2019 | -46.33 Mn |